832 related articles for article (PubMed ID: 16264061)
1. Optic neuritis with concurrent etanercept and isoniazid therapy.
Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA
Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061
[TBL] [Abstract][Full Text] [Related]
2. Parapharyngeal abscess in a patient receiving etanercept.
Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
[TBL] [Abstract][Full Text] [Related]
3. Optic neuritis with visual field defect--possible Ibuprofen-related toxicity.
Gamulescu MA; Schalke B; Schuierer G; Gabel VP
Ann Pharmacother; 2006 Mar; 40(3):571-3. PubMed ID: 16507621
[TBL] [Abstract][Full Text] [Related]
4. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
Prestinari F; Ferguglia G; Laria G
Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
[TBL] [Abstract][Full Text] [Related]
5. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
Lüke C; Dohmen C; Dietlein TS; Brunner R; Lüke M; Krieglstein GK
Klin Monbl Augenheilkd; 2007 Dec; 224(12):932-4. PubMed ID: 18260057
[TBL] [Abstract][Full Text] [Related]
6. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
7. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
8. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
Kocabay G; Erelel M; Tutkun IT; Ecder T
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
[No Abstract] [Full Text] [Related]
9. [A 76-year-old man with loss of vision and dementia].
Miyashita N; Imai H; Mori H; Kodera M; Shirai T; Mizuno Y
No To Shinkei; 1997 Aug; 49(8):773-82. PubMed ID: 9282374
[TBL] [Abstract][Full Text] [Related]
10. Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Yokoyama W; Takada K; Miyasaka N; Kohsaka H
BMJ Case Rep; 2014 Aug; 2014():bcr-2014-205779. PubMed ID: 25085953
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
12. [Short-term effect of megadose steroid therapy in optic neuritis].
Gerling J; Kommerell G
Klin Monbl Augenheilkd; 1992 Dec; 201(6):375-80. PubMed ID: 1287359
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
[TBL] [Abstract][Full Text] [Related]
14. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE
Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
[TBL] [Abstract][Full Text] [Related]
16. Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.
Simsek I; Erdem H; Pay S; Sobaci G; Dinc A
Ann Rheum Dis; 2007 Sep; 66(9):1255-8. PubMed ID: 17456525
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
[TBL] [Abstract][Full Text] [Related]
19. [Toxic optic neuropathy due to cisplatin therapy: a case report].
Martin M; Weber-Várszegi J; Flammer J
Klin Monbl Augenheilkd; 2005 Mar; 222(3):244-7. PubMed ID: 15785991
[TBL] [Abstract][Full Text] [Related]
20. Oral levofloxacin-induced optic neuritis progressing in loss of vision.
Das S; Mondal S
Ther Drug Monit; 2012 Apr; 34(2):124-5. PubMed ID: 22377742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
